Abstract
A phase III study on the concurrent use of oral pilocarpine to reduce hyposalivation and mucositis associated with radiation therapy in head and neck cancer patients. Final results of RTOG 97-09
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have